Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Temporal Dynamics of Multiple Sclerosis Risk: Integrating Genetic Susceptibility and Early-Life Exposures
Genetics
Temporal Dynamics of Multiple Sclerosis Risk: Integrating Genetic Susceptibility and Early-Life Exposures

19, Mar 2026

2
Temporal Dynamics of Multiple Sclerosis Risk: Integrating Genetic Susceptibility and Early-Life Exposures
Genetics
Decoding Biological Complexity: An Integrative Analysis of Molecular Systems

17, Mar 2026

3
Decoding the Genetic Architecture of Multiple Sclerosis: From Disease Susceptibility to Clinical Severity
Genetics
Decoding the Genetic Architecture of Multiple Sclerosis: From Disease Susceptibility to Clinical Severity

17, Mar 2026

4
Genetic and Gene Expression Signatures in Multiple Sclerosis: Insights from Modern Genomic Research
Genetics
Genetic and Gene Expression Signatures in Multiple Sclerosis: Insights from Modern Genomic Research

16, Mar 2026

5
Polygenic Risk Scores Reveal Genetic Stratification of Lifetime Multiple Sclerosis Risk
Genetics
Polygenic Risk Scores Reveal Genetic Stratification of Lifetime Multiple Sclerosis Risk

15, Mar 2026

Categories:
Genetics
Can We Predict Who Benefits from Glatiramer Acetate in MS?
Genetics
Can We Predict Who Benefits from Glatiramer Acetate in MS?

23, Jul 2025

Can We Predict Who Will Benefit From Fingolimod? A Step Toward Personalized Treatment in Multiple Sclerosis
Genetics
Can We Predict Who Will Benefit From Fingolimod? A Step Toward Personalized Treatment in Multiple Sclerosis

24, Jul 2025

Towards Personalized Treatment for Multiple Sclerosis: How Your Genes Can Help Choose the Right Therapy
Genetics
Towards Personalized Treatment for Multiple Sclerosis: How Your Genes Can Help Choose the Right Therapy

26, Jul 2025

Code of Multiple Sclerosis: New Insights into PPMS, RRMS, and the Promise of Ocrelizumab
Genetics
Code of Multiple Sclerosis: New Insights into PPMS, RRMS, and the Promise of Ocrelizumab

26, Jul 2025